Growth Metrics

Vanda Pharmaceuticals (VNDA) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -16.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -16.17%
Dec 31, 2025 -15.47%
Sep 30, 2025 -18.41%
Jun 30, 2025 -18.07%
Mar 31, 2025 -14.65%
Dec 31, 2024 -8.80%
Sep 30, 2024 -8.78%
Jun 30, 2024 -7.23%
Mar 31, 2024 -2.85%
Dec 31, 2023 0.63%
Sep 30, 2023 0.34%
Jun 30, 2023 1.92%
Mar 31, 2023 3.33%
Dec 31, 2022 1.03%
Sep 30, 2022 4.50%
Jun 30, 2022 7.29%
Mar 31, 2022 13.34%
Dec 31, 2021 8.90%
Sep 30, 2021 11.22%
Jun 30, 2021 11.19%
Mar 31, 2021 7.45%
Dec 31, 2020 4.91%
Sep 30, 2020 4.20%
Jun 30, 2020 4.94%
Mar 31, 2020 20.47%
Dec 31, 2019 20.37%
Sep 30, 2019 17.50%
Jun 30, 2019 14.35%
Mar 31, 2019 13.14%
Dec 31, 2018 15.69%
Sep 30, 2018 11.70%
Jun 30, 2018 9.58%
Mar 31, 2018 17.45%
Dec 31, 2017 19.48%
Sep 30, 2017 25.23%
Jun 30, 2017 22.55%
Mar 31, 2017 17.43%
Dec 31, 2016 13.01%
Sep 30, 2016 10.99%
Jun 30, 2016 23.28%
Mar 31, 2016 20.22%
Dec 31, 2015 0.20%
Sep 30, 2015 52.95%
Jun 30, 2015 20.29%
Mar 31, 2015 11.82%
Dec 31, 2014 7.36%
Sep 30, 2014 4.01%
Jun 30, 2014 2.88%
Mar 31, 2014 -4.59%
Dec 31, 2013 2.96%
Sep 30, 2013 20.09%